BrightSpring Health Services, Inc. Tangible Equity Unit financials
$188.43+2.24%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $12.91B | $10.07B |
| Gross profit | $1.52B | $1.27B |
| Gross margin | 11.8% | 12.6% |
| Operating income | $295.3M | $108.0M |
| Net income | $190.7M | -$18.1M |
| Net margin | 1.5% | −0.2% |
| Diluted EPS | $0.87 | $-0.09 |
| EBITDA | $459.5M | $312.4M |
| Operating cash flow | $490.2M | $23.8M |
| Free cash flow | $394.7M | -$57.1M |
| Diluted shares | 219.8M | 193.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $88.4M | $61.0M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $2.53B | $2.62B |
| Total assets | $6.41B | $5.93B |
| Total liabilities | $4.53B | $4.27B |
| Shareholders' equity | $1.88B | $1.65B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology